ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $468,124 | +77.6% | 24,821 | +10.8% | 0.01% | +100.0% |
| Q2 2019 | $263,612 | -5.3% | 22,397 | +9.8% | 0.00% | -20.0% |
| Q1 2019 | $278,378 | +26.2% | 20,394 | -5.2% | 0.01% | +25.0% |
| Q4 2018 | $220,549 | -38.4% | 21,517 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $358,258 | -99.9% | 21,517 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $339,968,000 | +24.4% | 21,517 | 0.0% | 0.01% | +50.0% |
| Q1 2018 | $273,266,000 | +119230.1% | 21,517 | +7.8% | 0.00% | +33.3% |
| Q4 2017 | $229,000 | -57.7% | 19,957 | -54.9% | 0.00% | 0.0% |
| Q3 2017 | $542,000 | +42.6% | 44,246 | +33.4% | 0.00% | 0.0% |
| Q2 2017 | $380,000 | -44.9% | 33,164 | 0.0% | 0.00% | -40.0% |
| Q1 2017 | $690,000 | -3.6% | 33,164 | -3.6% | 0.01% | 0.0% |
| Q4 2016 | $716,000 | -36.5% | 34,413 | 0.0% | 0.01% | -37.5% |
| Q3 2016 | $1,128,000 | +31.3% | 34,413 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $859,000 | +112.1% | 34,413 | +108.3% | 0.01% | +100.0% |
| Q1 2016 | $405,000 | -25.8% | 16,523 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $546,000 | +0.9% | 16,523 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $541,000 | -29.8% | 16,523 | +13.5% | 0.00% | -20.0% |
| Q2 2015 | $771,000 | +283.6% | 14,561 | +110.7% | 0.01% | +400.0% |
| Q4 2014 | $201,000 | – | 6,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |